Back to results
US 5,559,213 AGranted
Polyethylene-protein conjugates
AssigneeHoffmann-La Roche Inc.
InventorsJohn Hakimi, Patricia Kilian, Perry Rosen
Life of this patent
Estimating the term…
Abstract
The present invention is a physiologically active, substantially non-immunogenic water soluble polyethylene glycol protein conjugate having the same utility as the protein which forms the conjugate, without having the same properties of producing an immunogenic response possessed by the protein which forms this conjugate.
Claims4
A physiologically active IFN.alpha. conjugate of the formula ##STR10## wherein R is lower alkyl;
- R.sub.4 is lower alkyl or cyclo lower alkyl;
- m and n form any combination of numbers such that the conjugate and are selected such that the molecular weight of the conjugate, excluding the IFN.alpha., is from 300 to 30,000 daltons has a portion of the biological activity of the protein which forms the conjugate.
A physiologically active IL-1 conjugate of the formula ##STR11## wherein R is lower alkyl;
- R4 is lower alkyl or cyclo lower alkyl;
- m and n form any combination of numbers such that the conjugate has a portion of the biological activity of the IL-1 which forms the conjugate and are selected such that the molecular weight of the conjugate, excluding the IL-1, is from 300 to 30,000 daltons.
A physiologically active IL-1ra conjugate of the formula ##STR12## wherein R is lower alkyl;
- R4 is lower alkyl or cyclo lower alkyl;
- m and n form any combination of numbers such that the conjugate has a portion of the biological activity of the IL-1 which forms the conjugate and are selected such that the molecular weight of the conjugate, excluding the IL-1ra, is from 300 to 30,000 daltons.
Dependencies are inferred from the claim text.